CI
AXSM icon

CacheTech Inc’s Axsome Therapeutics AXSM Stock Holding History

CacheTech Inc’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,169
Closed -$389K – 186
2025
Q4 		$389K Hold
2,169
– – 0.07% 136
2025
Q3 		$259K Hold
2,169
– – 0.05% 157
2025
Q2 		$225K Hold
2,169
– – 0.04% 162
2025
Q1 		$251K Buy
+2,169
New +$247K 0.05% 120

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CacheTech Inc's AXSM Position: Q1 2026 in Review

CacheTech Inc sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 2,169 shares — an estimated $389K sold.

CacheTech Inc first reported a position in AXSM in Q1 2025 and held it in 4 quarters. The position peaked at $389K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • CacheTech Inc reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CacheTech Inc sold 2,169 Axsome Therapeutics shares in Q1 2026, an estimated $389K.
  • CacheTech Inc first reported a position in Axsome Therapeutics in Q1 2025 and held it in 4 quarters.
  • CacheTech Inc's Axsome Therapeutics position peaked at $389K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on CacheTech Inc's 13F filing for Q1 2026, filed 12 May 2026.